The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor PIK3CA genotype and prognosis: A pooled analysis of 4,241 patients (pts) with early-stage breast cancer (BC).
 
Dimitrios Zardavas
No Relationships to Disclose
 
Luc Te Marvelde
No Relationships to Disclose
 
Roger Milne
No Relationships to Disclose
 
Heikki Joensuu
No Relationships to Disclose
 
Mary Ellen Moynahan
No Relationships to Disclose
 
Bryan Hennessy
No Relationships to Disclose
 
Ivan Bieche
No Relationships to Disclose
 
Lao H Saal
No Relationships to Disclose
 
Olle Stal
No Relationships to Disclose
 
Barry Iacopetta
No Relationships to Disclose
 
Jeanette Dupont Jensen
No Relationships to Disclose
 
Sandra O'Toole
No Relationships to Disclose
 
Mattia Barbareschi
No Relationships to Disclose
 
Shinzaburo Noguchi
No Relationships to Disclose
 
Enrique Lerma
No Relationships to Disclose
 
Qing Wang
No Relationships to Disclose
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Invivis; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Symphony Evolution; Synthon; Verastem
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Invivis (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Symphony Evolution (Inst); Synthon (Inst); Verastem (Inst)
 
Christos Sotiriou
No Relationships to Disclose
 
Stefan Michiels
No Relationships to Disclose
 
Sherene Loi
No Relationships to Disclose